Pharma Mar | PHM - Current Assets

Stock Price
78.70
Daily Change
-0.55 -0.69%
Monthly
-2.36%
Yearly
-19.07%
Q1 Forecast
77.09

Pharma Mar reported EUR242.88M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Akebia Therapeutics USD 258.34M 23.68M Sep/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Almirall EUR 714.05M 27.09M Jun/2025
Avita Medical AUD 36.25M 20.75M Jun/2025
Dianthus Therapeutics USD 413.82M 150.22M Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Moderna USD 6.54B 54M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Pharma Mar EUR 242.88M 6.52M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Viatris USD 9.95B 176.8M Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025